Dedicated Connectivity for the Pharmaceutical Industry in Puerto Rico
Manufacturing control systems, process validation, and batch traceability depend on constant connectivity. An interruption can mean the loss of an entire batch, a finding in a regulatory audit, or worse, a reportable deviation to the FDA.
In an industry where every minute of production has critical value, and the regulator accepts no infrastructure excuses, connectivity cannot be a point of failure.
• Industry 4.0 and Manufacturing 4.0: advanced automation, digital twins, and cloud-based MES systems require stable, low-latency connectivity.
• Artificial intelligence in quality: AI platforms for real-time anomaly detection, statistical process control, and equipment failure prediction.
• IoT cold chain monitoring: connected sensors that continuously report temperature, humidity, and environmental conditions.
• FDA 21 CFR Part 11: electronic records systems and digital signatures must always be available and traceable.
• Cloud-based enterprise management platforms: ERP systems and product lifecycle management are the modern operational standard in the industry.
DNA provides two completely independent internet routes, fiber optic and microwave, with automatic failover in milliseconds. Automatic continuity means that when one route fails, the other takes over instantly and transparently, without any system detecting it as an interruption.
No error screens. No manual reconnection. No downtime window. The transition occurs before any application, sensor, or system registers an anomaly. No SCADA system goes down. No FDA report is interrupted. No IoT sensor loses communication. With dedicated bandwidth and a documented SLA, DNA also facilitates the infrastructure audits that regulators require.
• SCADA and DCS systems are always connected: critical process control without interruptions.
• Uninterrupted batch traceability: MES and ERP systems never lose communication during an audit.
• 24/7 cold chain monitoring: IoT sensors report in real time without outages.
• Support for FDA and cGMP compliance: stable network infrastructure is documentable evidence in audits.
• Connectivity between plants and headquarters: DNA enables continuous communication across multiple locations.
• Dedicated bandwidth with CIR: guaranteed speed for large data transfers between systems.
In pharmaceutical manufacturing, every minute of production has critical value. DNA guarantees that a network failure is never the reason for a batch deviation or a regulatory finding.
